SVF 002
Alternative Names: SVF-002Latest Information Update: 17 Jul 2023
At a glance
- Originator Svenska VaccinFabriken
- Developer Karolinska University Hospital; Svenska VaccinFabriken
- Class COVID-19 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I COVID 2019 infections